nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.178	0.359	CbGbCtD
Dabigatran etexilate—UGT2B7—Losartan—type 2 diabetes mellitus	0.104	0.21	CbGbCtD
Dabigatran etexilate—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0592	0.119	CbGbCtD
Dabigatran etexilate—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0528	0.106	CbGbCtD
Dabigatran etexilate—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0382	0.0769	CbGbCtD
Dabigatran etexilate—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0262	0.0528	CbGbCtD
Dabigatran etexilate—ABCB1—Glyburide—type 2 diabetes mellitus	0.0195	0.0394	CbGbCtD
Dabigatran etexilate—ABCB1—Losartan—type 2 diabetes mellitus	0.0179	0.036	CbGbCtD
Dabigatran etexilate—F2—leg—type 2 diabetes mellitus	0.00856	0.108	CbGeAlD
Dabigatran etexilate—F2—hindlimb—type 2 diabetes mellitus	0.00765	0.0968	CbGeAlD
Dabigatran etexilate—F2—artery—type 2 diabetes mellitus	0.00469	0.0593	CbGeAlD
Dabigatran etexilate—UGT2B15—islet of Langerhans—type 2 diabetes mellitus	0.00411	0.052	CbGeAlD
Dabigatran etexilate—F2—endothelium—type 2 diabetes mellitus	0.00396	0.0501	CbGeAlD
Dabigatran etexilate—UGT2B15—pancreas—type 2 diabetes mellitus	0.00289	0.0366	CbGeAlD
Dabigatran etexilate—CES2—islet of Langerhans—type 2 diabetes mellitus	0.00251	0.0318	CbGeAlD
Dabigatran etexilate—NQO2—islet of Langerhans—type 2 diabetes mellitus	0.00224	0.0284	CbGeAlD
Dabigatran etexilate—UGT1A9—kidney—type 2 diabetes mellitus	0.0022	0.0279	CbGeAlD
Dabigatran etexilate—CES2—retina—type 2 diabetes mellitus	0.00215	0.0272	CbGeAlD
Dabigatran etexilate—CES2—nephron tubule—type 2 diabetes mellitus	0.00202	0.0256	CbGeAlD
Dabigatran etexilate—UGT2B15—liver—type 2 diabetes mellitus	0.00184	0.0233	CbGeAlD
Dabigatran etexilate—CES2—cardiovascular system—type 2 diabetes mellitus	0.00182	0.023	CbGeAlD
Dabigatran etexilate—NQO2—nephron tubule—type 2 diabetes mellitus	0.00181	0.0229	CbGeAlD
Dabigatran etexilate—UGT2B7—kidney—type 2 diabetes mellitus	0.00178	0.0225	CbGeAlD
Dabigatran etexilate—CES2—kidney—type 2 diabetes mellitus	0.00178	0.0225	CbGeAlD
Dabigatran etexilate—CES2—pancreas—type 2 diabetes mellitus	0.00177	0.0223	CbGeAlD
Dabigatran etexilate—CES2—cortex of kidney—type 2 diabetes mellitus	0.00173	0.0219	CbGeAlD
Dabigatran etexilate—F2—cardiovascular system—type 2 diabetes mellitus	0.00163	0.0206	CbGeAlD
Dabigatran etexilate—CES2—adipose tissue—type 2 diabetes mellitus	0.0016	0.0203	CbGeAlD
Dabigatran etexilate—F2—kidney—type 2 diabetes mellitus	0.00159	0.0202	CbGeAlD
Dabigatran etexilate—NQO2—kidney—type 2 diabetes mellitus	0.00159	0.0201	CbGeAlD
Dabigatran etexilate—NQO2—pancreas—type 2 diabetes mellitus	0.00158	0.02	CbGeAlD
Dabigatran etexilate—NQO2—cortex of kidney—type 2 diabetes mellitus	0.00155	0.0196	CbGeAlD
Dabigatran etexilate—CES1—cardiovascular system—type 2 diabetes mellitus	0.0015	0.0189	CbGeAlD
Dabigatran etexilate—NQO2—adipose tissue—type 2 diabetes mellitus	0.00143	0.0181	CbGeAlD
Dabigatran etexilate—UGT1A9—liver—type 2 diabetes mellitus	0.00139	0.0176	CbGeAlD
Dabigatran etexilate—CES1—adipose tissue—type 2 diabetes mellitus	0.00132	0.0167	CbGeAlD
Dabigatran etexilate—UGT2B7—liver—type 2 diabetes mellitus	0.00112	0.0142	CbGeAlD
Dabigatran etexilate—CES2—liver—type 2 diabetes mellitus	0.00112	0.0142	CbGeAlD
Dabigatran etexilate—F2—liver—type 2 diabetes mellitus	0.00101	0.0127	CbGeAlD
Dabigatran etexilate—NQO2—liver—type 2 diabetes mellitus	0.001	0.0127	CbGeAlD
Dabigatran etexilate—CES1—liver—type 2 diabetes mellitus	0.000925	0.0117	CbGeAlD
Dabigatran etexilate—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000484	0.00613	CbGeAlD
Dabigatran etexilate—ABCB1—retina—type 2 diabetes mellitus	0.000414	0.00524	CbGeAlD
Dabigatran etexilate—ABCB1—nephron tubule—type 2 diabetes mellitus	0.00039	0.00493	CbGeAlD
Dabigatran etexilate—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.00035	0.00443	CbGeAlD
Dabigatran etexilate—ABCB1—kidney—type 2 diabetes mellitus	0.000343	0.00434	CbGeAlD
Dabigatran etexilate—ABCB1—pancreas—type 2 diabetes mellitus	0.000341	0.00431	CbGeAlD
Dabigatran etexilate—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000334	0.00422	CbGeAlD
Dabigatran etexilate—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000309	0.00391	CbGeAlD
Dabigatran etexilate—ABCB1—liver—type 2 diabetes mellitus	0.000217	0.00274	CbGeAlD
Dabigatran etexilate—Chest pain—Orlistat—type 2 diabetes mellitus	0.000201	0.000774	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000201	0.000772	CcSEcCtD
Dabigatran etexilate—Epistaxis—Ramipril—type 2 diabetes mellitus	0.0002	0.00077	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.0002	0.000768	CcSEcCtD
Dabigatran etexilate—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000199	0.000766	CcSEcCtD
Dabigatran etexilate—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000198	0.000763	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000196	0.000755	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000195	0.000752	CcSEcCtD
Dabigatran etexilate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000195	0.000752	CcSEcCtD
Dabigatran etexilate—Syncope—Metformin—type 2 diabetes mellitus	0.000195	0.000751	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000195	0.000751	CcSEcCtD
Dabigatran etexilate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000195	0.000749	CcSEcCtD
Dabigatran etexilate—Infection—Valsartan—type 2 diabetes mellitus	0.000194	0.000746	CcSEcCtD
Dabigatran etexilate—Rash—Glipizide—type 2 diabetes mellitus	0.000194	0.000745	CcSEcCtD
Dabigatran etexilate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000193	0.000745	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000193	0.000744	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000193	0.000744	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000193	0.000742	CcSEcCtD
Dabigatran etexilate—Headache—Glipizide—type 2 diabetes mellitus	0.000192	0.000741	CcSEcCtD
Dabigatran etexilate—Palpitations—Metformin—type 2 diabetes mellitus	0.000192	0.00074	CcSEcCtD
Dabigatran etexilate—Shock—Valsartan—type 2 diabetes mellitus	0.000192	0.000738	CcSEcCtD
Dabigatran etexilate—Infection—Orlistat—type 2 diabetes mellitus	0.000191	0.000737	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000191	0.000736	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000191	0.000736	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000191	0.000735	CcSEcCtD
Dabigatran etexilate—Flatulence—Losartan—type 2 diabetes mellitus	0.00019	0.000733	CcSEcCtD
Dabigatran etexilate—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00019	0.00073	CcSEcCtD
Dabigatran etexilate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00019	0.00073	CcSEcCtD
Dabigatran etexilate—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000189	0.000729	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000189	0.000728	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000189	0.000727	CcSEcCtD
Dabigatran etexilate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000189	0.000727	CcSEcCtD
Dabigatran etexilate—Hypertension—Metformin—type 2 diabetes mellitus	0.000188	0.000723	CcSEcCtD
Dabigatran etexilate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000188	0.000723	CcSEcCtD
Dabigatran etexilate—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000188	0.000722	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000188	0.000722	CcSEcCtD
Dabigatran etexilate—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000187	0.00072	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000187	0.00072	CcSEcCtD
Dabigatran etexilate—Back pain—Losartan—type 2 diabetes mellitus	0.000187	0.000719	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000187	0.000719	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000187	0.000719	CcSEcCtD
Dabigatran etexilate—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000186	0.000714	CcSEcCtD
Dabigatran etexilate—Chest pain—Metformin—type 2 diabetes mellitus	0.000185	0.000713	CcSEcCtD
Dabigatran etexilate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000184	0.000709	CcSEcCtD
Dabigatran etexilate—Syncope—Irbesartan—type 2 diabetes mellitus	0.000184	0.000709	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000184	0.000708	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000183	0.000705	CcSEcCtD
Dabigatran etexilate—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000183	0.000704	CcSEcCtD
Dabigatran etexilate—Nausea—Glipizide—type 2 diabetes mellitus	0.000182	0.000702	CcSEcCtD
Dabigatran etexilate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000182	0.000701	CcSEcCtD
Dabigatran etexilate—Hypotension—Valsartan—type 2 diabetes mellitus	0.000182	0.000701	CcSEcCtD
Dabigatran etexilate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000182	0.000699	CcSEcCtD
Dabigatran etexilate—Constipation—Gliclazide—type 2 diabetes mellitus	0.000182	0.000699	CcSEcCtD
Dabigatran etexilate—Rash—Glimepiride—type 2 diabetes mellitus	0.000181	0.000696	CcSEcCtD
Dabigatran etexilate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000181	0.000695	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00018	0.000695	CcSEcCtD
Dabigatran etexilate—Rash—Sitagliptin—type 2 diabetes mellitus	0.00018	0.000693	CcSEcCtD
Dabigatran etexilate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00018	0.000693	CcSEcCtD
Dabigatran etexilate—Headache—Glimepiride—type 2 diabetes mellitus	0.00018	0.000691	CcSEcCtD
Dabigatran etexilate—Cough—Irbesartan—type 2 diabetes mellitus	0.000179	0.00069	CcSEcCtD
Dabigatran etexilate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000179	0.000689	CcSEcCtD
Dabigatran etexilate—Anaemia—Losartan—type 2 diabetes mellitus	0.000179	0.000687	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000178	0.000684	CcSEcCtD
Dabigatran etexilate—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000177	0.000682	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000177	0.000681	CcSEcCtD
Dabigatran etexilate—Angioedema—Losartan—type 2 diabetes mellitus	0.000177	0.00068	CcSEcCtD
Dabigatran etexilate—Infection—Metformin—type 2 diabetes mellitus	0.000176	0.000679	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000176	0.000676	CcSEcCtD
Dabigatran etexilate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000175	0.000673	CcSEcCtD
Dabigatran etexilate—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000175	0.000673	CcSEcCtD
Dabigatran etexilate—Shock—Metformin—type 2 diabetes mellitus	0.000175	0.000672	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000174	0.00067	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000174	0.00067	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000174	0.000669	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000174	0.000669	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000174	0.000668	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000174	0.000668	CcSEcCtD
Dabigatran etexilate—Syncope—Losartan—type 2 diabetes mellitus	0.000173	0.000667	CcSEcCtD
Dabigatran etexilate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000172	0.000664	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.000662	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000172	0.000661	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.00066	CcSEcCtD
Dabigatran etexilate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000171	0.000658	CcSEcCtD
Dabigatran etexilate—Palpitations—Losartan—type 2 diabetes mellitus	0.000171	0.000657	CcSEcCtD
Dabigatran etexilate—Nausea—Glimepiride—type 2 diabetes mellitus	0.00017	0.000655	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.00017	0.000654	CcSEcCtD
Dabigatran etexilate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00017	0.000653	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00017	0.000653	CcSEcCtD
Dabigatran etexilate—Asthenia—Glyburide—type 2 diabetes mellitus	0.00017	0.000653	CcSEcCtD
Dabigatran etexilate—Cough—Losartan—type 2 diabetes mellitus	0.000169	0.000649	CcSEcCtD
Dabigatran etexilate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000169	0.000649	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000168	0.000648	CcSEcCtD
Dabigatran etexilate—Fatigue—Valsartan—type 2 diabetes mellitus	0.000168	0.000647	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000168	0.000646	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000168	0.000645	CcSEcCtD
Dabigatran etexilate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000167	0.000644	CcSEcCtD
Dabigatran etexilate—Constipation—Valsartan—type 2 diabetes mellitus	0.000167	0.000642	CcSEcCtD
Dabigatran etexilate—Infection—Irbesartan—type 2 diabetes mellitus	0.000166	0.000641	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000166	0.00064	CcSEcCtD
Dabigatran etexilate—Fatigue—Orlistat—type 2 diabetes mellitus	0.000166	0.000639	CcSEcCtD
Dabigatran etexilate—Hypotension—Metformin—type 2 diabetes mellitus	0.000166	0.000639	CcSEcCtD
Dabigatran etexilate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000166	0.000638	CcSEcCtD
Dabigatran etexilate—Shock—Irbesartan—type 2 diabetes mellitus	0.000165	0.000635	CcSEcCtD
Dabigatran etexilate—Chest pain—Losartan—type 2 diabetes mellitus	0.000165	0.000633	CcSEcCtD
Dabigatran etexilate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000165	0.000633	CcSEcCtD
Dabigatran etexilate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000164	0.000633	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000164	0.000633	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000164	0.000632	CcSEcCtD
Dabigatran etexilate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000163	0.000627	CcSEcCtD
Dabigatran etexilate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000163	0.000627	CcSEcCtD
Dabigatran etexilate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000163	0.000627	CcSEcCtD
Dabigatran etexilate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000162	0.000623	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000162	0.000623	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000162	0.000622	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000159	0.000614	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000158	0.000609	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000158	0.000607	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000158	0.000606	CcSEcCtD
Dabigatran etexilate—Infection—Losartan—type 2 diabetes mellitus	0.000157	0.000603	CcSEcCtD
Dabigatran etexilate—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000157	0.000603	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000156	0.000602	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000156	0.000602	CcSEcCtD
Dabigatran etexilate—Shock—Losartan—type 2 diabetes mellitus	0.000155	0.000597	CcSEcCtD
Dabigatran etexilate—Urticaria—Valsartan—type 2 diabetes mellitus	0.000155	0.000596	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000155	0.000595	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000154	0.000594	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000154	0.000593	CcSEcCtD
Dabigatran etexilate—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000154	0.000591	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000153	0.00059	CcSEcCtD
Dabigatran etexilate—Fatigue—Metformin—type 2 diabetes mellitus	0.000153	0.000589	CcSEcCtD
Dabigatran etexilate—Urticaria—Orlistat—type 2 diabetes mellitus	0.000153	0.000589	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000153	0.000588	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000152	0.000586	CcSEcCtD
Dabigatran etexilate—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000152	0.000586	CcSEcCtD
Dabigatran etexilate—Constipation—Metformin—type 2 diabetes mellitus	0.000152	0.000584	CcSEcCtD
Dabigatran etexilate—Angioedema—Ramipril—type 2 diabetes mellitus	0.000151	0.000583	CcSEcCtD
Dabigatran etexilate—Vomiting—Glyburide—type 2 diabetes mellitus	0.00015	0.000578	CcSEcCtD
Dabigatran etexilate—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00015	0.000578	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000149	0.000575	CcSEcCtD
Dabigatran etexilate—Rash—Glyburide—type 2 diabetes mellitus	0.000149	0.000574	CcSEcCtD
Dabigatran etexilate—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000149	0.000573	CcSEcCtD
Dabigatran etexilate—Syncope—Ramipril—type 2 diabetes mellitus	0.000149	0.000572	CcSEcCtD
Dabigatran etexilate—Headache—Glyburide—type 2 diabetes mellitus	0.000148	0.00057	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000148	0.000568	CcSEcCtD
Dabigatran etexilate—Hypotension—Losartan—type 2 diabetes mellitus	0.000147	0.000567	CcSEcCtD
Dabigatran etexilate—Palpitations—Ramipril—type 2 diabetes mellitus	0.000146	0.000564	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000146	0.000561	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000145	0.000559	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000145	0.000559	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000145	0.000557	CcSEcCtD
Dabigatran etexilate—Cough—Ramipril—type 2 diabetes mellitus	0.000145	0.000557	CcSEcCtD
Dabigatran etexilate—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000144	0.000556	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000144	0.000553	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000144	0.000553	CcSEcCtD
Dabigatran etexilate—Constipation—Irbesartan—type 2 diabetes mellitus	0.000143	0.000552	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000142	0.000546	CcSEcCtD
Dabigatran etexilate—Urticaria—Metformin—type 2 diabetes mellitus	0.000141	0.000543	CcSEcCtD
Dabigatran etexilate—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000141	0.000543	CcSEcCtD
Dabigatran etexilate—Chest pain—Ramipril—type 2 diabetes mellitus	0.000141	0.000543	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000141	0.000541	CcSEcCtD
Dabigatran etexilate—Nausea—Glyburide—type 2 diabetes mellitus	0.00014	0.00054	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00014	0.00054	CcSEcCtD
Dabigatran etexilate—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00014	0.00054	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00014	0.000539	CcSEcCtD
Dabigatran etexilate—Asthenia—Valsartan—type 2 diabetes mellitus	0.00014	0.000539	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000139	0.000534	CcSEcCtD
Dabigatran etexilate—Asthenia—Orlistat—type 2 diabetes mellitus	0.000138	0.000532	CcSEcCtD
Dabigatran etexilate—Pruritus—Valsartan—type 2 diabetes mellitus	0.000138	0.000531	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000137	0.000527	CcSEcCtD
Dabigatran etexilate—Pruritus—Orlistat—type 2 diabetes mellitus	0.000136	0.000525	CcSEcCtD
Dabigatran etexilate—Fatigue—Losartan—type 2 diabetes mellitus	0.000136	0.000523	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000135	0.00052	CcSEcCtD
Dabigatran etexilate—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000135	0.000519	CcSEcCtD
Dabigatran etexilate—Constipation—Losartan—type 2 diabetes mellitus	0.000135	0.000519	CcSEcCtD
Dabigatran etexilate—Rash—Gliclazide—type 2 diabetes mellitus	0.000134	0.000515	CcSEcCtD
Dabigatran etexilate—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000134	0.000515	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000133	0.000514	CcSEcCtD
Dabigatran etexilate—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000133	0.000512	CcSEcCtD
Dabigatran etexilate—Shock—Ramipril—type 2 diabetes mellitus	0.000133	0.000512	CcSEcCtD
Dabigatran etexilate—Headache—Gliclazide—type 2 diabetes mellitus	0.000133	0.000512	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000133	0.00051	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000132	0.00051	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000132	0.00051	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000132	0.000507	CcSEcCtD
Dabigatran etexilate—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.000506	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000129	0.000496	CcSEcCtD
Dabigatran etexilate—Dizziness—Valsartan—type 2 diabetes mellitus	0.000129	0.000496	CcSEcCtD
Dabigatran etexilate—Dizziness—Orlistat—type 2 diabetes mellitus	0.000127	0.00049	CcSEcCtD
Dabigatran etexilate—Asthenia—Metformin—type 2 diabetes mellitus	0.000127	0.00049	CcSEcCtD
Dabigatran etexilate—Hypotension—Ramipril—type 2 diabetes mellitus	0.000126	0.000486	CcSEcCtD
Dabigatran etexilate—Nausea—Gliclazide—type 2 diabetes mellitus	0.000126	0.000485	CcSEcCtD
Dabigatran etexilate—Pruritus—Metformin—type 2 diabetes mellitus	0.000126	0.000484	CcSEcCtD
Dabigatran etexilate—Urticaria—Losartan—type 2 diabetes mellitus	0.000125	0.000482	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000125	0.00048	CcSEcCtD
Dabigatran etexilate—Vomiting—Valsartan—type 2 diabetes mellitus	0.000124	0.000477	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000123	0.000475	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000123	0.000474	CcSEcCtD
Dabigatran etexilate—Rash—Valsartan—type 2 diabetes mellitus	0.000123	0.000473	CcSEcCtD
Dabigatran etexilate—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000123	0.000473	CcSEcCtD
Dabigatran etexilate—Vomiting—Orlistat—type 2 diabetes mellitus	0.000123	0.000472	CcSEcCtD
Dabigatran etexilate—Headache—Valsartan—type 2 diabetes mellitus	0.000122	0.00047	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000122	0.000468	CcSEcCtD
Dabigatran etexilate—Rash—Orlistat—type 2 diabetes mellitus	0.000121	0.000468	CcSEcCtD
Dabigatran etexilate—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000121	0.000467	CcSEcCtD
Dabigatran etexilate—Headache—Orlistat—type 2 diabetes mellitus	0.000121	0.000465	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000121	0.000464	CcSEcCtD
Dabigatran etexilate—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00012	0.000463	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000119	0.000458	CcSEcCtD
Dabigatran etexilate—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000119	0.000456	CcSEcCtD
Dabigatran etexilate—Dizziness—Metformin—type 2 diabetes mellitus	0.000117	0.000452	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000117	0.000449	CcSEcCtD
Dabigatran etexilate—Fatigue—Ramipril—type 2 diabetes mellitus	0.000117	0.000449	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000116	0.000447	CcSEcCtD
Dabigatran etexilate—Nausea—Valsartan—type 2 diabetes mellitus	0.000116	0.000446	CcSEcCtD
Dabigatran etexilate—Constipation—Ramipril—type 2 diabetes mellitus	0.000116	0.000445	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000115	0.000441	CcSEcCtD
Dabigatran etexilate—Nausea—Orlistat—type 2 diabetes mellitus	0.000114	0.000441	CcSEcCtD
Dabigatran etexilate—Asthenia—Losartan—type 2 diabetes mellitus	0.000113	0.000436	CcSEcCtD
Dabigatran etexilate—Vomiting—Metformin—type 2 diabetes mellitus	0.000113	0.000435	CcSEcCtD
Dabigatran etexilate—Rash—Metformin—type 2 diabetes mellitus	0.000112	0.000431	CcSEcCtD
Dabigatran etexilate—Dermatitis—Metformin—type 2 diabetes mellitus	0.000112	0.000431	CcSEcCtD
Dabigatran etexilate—Pruritus—Losartan—type 2 diabetes mellitus	0.000112	0.000429	CcSEcCtD
Dabigatran etexilate—Headache—Metformin—type 2 diabetes mellitus	0.000111	0.000428	CcSEcCtD
Dabigatran etexilate—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000111	0.000427	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000111	0.000426	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000108	0.000415	CcSEcCtD
Dabigatran etexilate—Urticaria—Ramipril—type 2 diabetes mellitus	0.000107	0.000413	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000107	0.000411	CcSEcCtD
Dabigatran etexilate—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000107	0.00041	CcSEcCtD
Dabigatran etexilate—Rash—Irbesartan—type 2 diabetes mellitus	0.000106	0.000407	CcSEcCtD
Dabigatran etexilate—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000106	0.000406	CcSEcCtD
Dabigatran etexilate—Nausea—Metformin—type 2 diabetes mellitus	0.000105	0.000406	CcSEcCtD
Dabigatran etexilate—Headache—Irbesartan—type 2 diabetes mellitus	0.000105	0.000404	CcSEcCtD
Dabigatran etexilate—Dizziness—Losartan—type 2 diabetes mellitus	0.000104	0.000401	CcSEcCtD
Dabigatran etexilate—Vomiting—Losartan—type 2 diabetes mellitus	0.0001	0.000386	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.96e-05	0.000383	CcSEcCtD
Dabigatran etexilate—Nausea—Irbesartan—type 2 diabetes mellitus	9.95e-05	0.000383	CcSEcCtD
Dabigatran etexilate—Rash—Losartan—type 2 diabetes mellitus	9.94e-05	0.000383	CcSEcCtD
Dabigatran etexilate—Dermatitis—Losartan—type 2 diabetes mellitus	9.94e-05	0.000382	CcSEcCtD
Dabigatran etexilate—Headache—Losartan—type 2 diabetes mellitus	9.88e-05	0.00038	CcSEcCtD
Dabigatran etexilate—Asthenia—Ramipril—type 2 diabetes mellitus	9.7e-05	0.000373	CcSEcCtD
Dabigatran etexilate—Pruritus—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000368	CcSEcCtD
Dabigatran etexilate—Nausea—Losartan—type 2 diabetes mellitus	9.37e-05	0.000361	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.25e-05	0.000356	CcSEcCtD
Dabigatran etexilate—Dizziness—Ramipril—type 2 diabetes mellitus	8.94e-05	0.000344	CcSEcCtD
Dabigatran etexilate—Vomiting—Ramipril—type 2 diabetes mellitus	8.6e-05	0.000331	CcSEcCtD
Dabigatran etexilate—Rash—Ramipril—type 2 diabetes mellitus	8.53e-05	0.000328	CcSEcCtD
Dabigatran etexilate—Dermatitis—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000328	CcSEcCtD
Dabigatran etexilate—Headache—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000326	CcSEcCtD
Dabigatran etexilate—Nausea—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000309	CcSEcCtD
Dabigatran etexilate—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	2.07e-05	0.000126	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	2.06e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HBA1—type 2 diabetes mellitus	2.06e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LIPC—type 2 diabetes mellitus	2.06e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GCK—type 2 diabetes mellitus	2.06e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP1A2—type 2 diabetes mellitus	2.06e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC2A1—type 2 diabetes mellitus	2.06e-05	0.000125	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP11A1—type 2 diabetes mellitus	2.05e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	2.04e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	2.04e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2.04e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	2.02e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	2.02e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC9A1—type 2 diabetes mellitus	2.01e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.01e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP3A4—type 2 diabetes mellitus	2e-05	0.000122	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CETP—type 2 diabetes mellitus	1.99e-05	0.000121	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.98e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.97e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.97e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC2A4—type 2 diabetes mellitus	1.97e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GCG—type 2 diabetes mellitus	1.97e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.97e-05	0.00012	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.96e-05	0.000119	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—type 2 diabetes mellitus	1.95e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.95e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.94e-05	0.000118	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.93e-05	0.000117	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.93e-05	0.000117	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.91e-05	0.000116	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	1.91e-05	0.000116	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.91e-05	0.000116	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SRC—type 2 diabetes mellitus	1.9e-05	0.000115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	1.87e-05	0.000114	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.86e-05	0.000113	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SREBF1—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SNAP25—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PSMD6—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.85e-05	0.000112	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CTGF—type 2 diabetes mellitus	1.81e-05	0.00011	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.8e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMGCR—type 2 diabetes mellitus	1.8e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.79e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.79e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.78e-05	0.000108	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.77e-05	0.000108	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.77e-05	0.000107	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.77e-05	0.000107	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADRA2A—type 2 diabetes mellitus	1.76e-05	0.000107	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.74e-05	0.000106	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.73e-05	0.000105	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.71e-05	0.000104	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.7e-05	0.000103	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GNB3—type 2 diabetes mellitus	1.7e-05	0.000103	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TGFB1—type 2 diabetes mellitus	1.7e-05	0.000103	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—HMOX1—type 2 diabetes mellitus	1.69e-05	0.000103	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2E1—type 2 diabetes mellitus	1.69e-05	0.000103	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.69e-05	0.000102	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.69e-05	0.000102	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC2A1—type 2 diabetes mellitus	1.67e-05	0.000101	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP1A2—type 2 diabetes mellitus	1.67e-05	0.000101	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAT—type 2 diabetes mellitus	1.67e-05	0.000101	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.65e-05	0.0001	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.65e-05	0.0001	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.64e-05	9.99e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.64e-05	9.94e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP3A4—type 2 diabetes mellitus	1.63e-05	9.89e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.62e-05	9.87e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.62e-05	9.86e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.62e-05	9.84e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOB—type 2 diabetes mellitus	1.62e-05	9.84e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GCG—type 2 diabetes mellitus	1.6e-05	9.73e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC2A4—type 2 diabetes mellitus	1.6e-05	9.73e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTM1—type 2 diabetes mellitus	1.58e-05	9.57e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.57e-05	9.53e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.57e-05	9.53e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.57e-05	9.53e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.57e-05	9.53e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LPL—type 2 diabetes mellitus	1.55e-05	9.39e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.54e-05	9.38e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.54e-05	9.33e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.52e-05	9.25e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADCY5—type 2 diabetes mellitus	1.51e-05	9.19e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GPX1—type 2 diabetes mellitus	1.51e-05	9.16e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.5e-05	9.14e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.5e-05	9.14e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.5e-05	9.12e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.5e-05	9.12e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.5e-05	9.08e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.49e-05	9.04e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.47e-05	8.95e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CD36—type 2 diabetes mellitus	1.47e-05	8.92e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.45e-05	8.82e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPP2CA—type 2 diabetes mellitus	1.45e-05	8.81e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.45e-05	8.79e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.45e-05	8.79e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.45e-05	8.78e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.44e-05	8.74e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.43e-05	8.68e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	1.42e-05	8.64e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	1.4e-05	8.52e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	1.4e-05	8.49e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	1.4e-05	8.49e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	1.4e-05	8.49e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MTHFR—type 2 diabetes mellitus	1.39e-05	8.46e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.39e-05	8.42e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.38e-05	8.38e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GNB3—type 2 diabetes mellitus	1.38e-05	8.38e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—HMOX1—type 2 diabetes mellitus	1.37e-05	8.34e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARA—type 2 diabetes mellitus	1.37e-05	8.3e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.36e-05	8.24e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAT—type 2 diabetes mellitus	1.36e-05	8.23e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.35e-05	8.21e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.35e-05	8.17e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.33e-05	8.1e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AGT—type 2 diabetes mellitus	1.32e-05	8.03e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOB—type 2 diabetes mellitus	1.32e-05	7.99e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	1.31e-05	7.99e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.3e-05	7.9e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CALM1—type 2 diabetes mellitus	1.3e-05	7.9e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOE—type 2 diabetes mellitus	1.3e-05	7.87e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	1.29e-05	7.83e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	1.29e-05	7.82e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOA1—type 2 diabetes mellitus	1.28e-05	7.78e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTM1—type 2 diabetes mellitus	1.28e-05	7.77e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.28e-05	7.76e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	1.26e-05	7.66e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LPL—type 2 diabetes mellitus	1.26e-05	7.63e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—C3—type 2 diabetes mellitus	1.25e-05	7.58e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	1.23e-05	7.48e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADCY5—type 2 diabetes mellitus	1.23e-05	7.47e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GPX1—type 2 diabetes mellitus	1.23e-05	7.45e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	1.2e-05	7.32e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	1.2e-05	7.3e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CD36—type 2 diabetes mellitus	1.19e-05	7.25e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.19e-05	7.23e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.19e-05	7.22e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.19e-05	7.22e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.19e-05	7.22e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.19e-05	7.22e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.19e-05	7.21e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.19e-05	7.2e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT1—type 2 diabetes mellitus	1.18e-05	7.17e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPP2CA—type 2 diabetes mellitus	1.18e-05	7.16e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.17e-05	7.08e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.16e-05	7.06e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.16e-05	7.06e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.15e-05	6.98e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.14e-05	6.92e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MTHFR—type 2 diabetes mellitus	1.13e-05	6.87e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—type 2 diabetes mellitus	1.13e-05	6.86e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARA—type 2 diabetes mellitus	1.11e-05	6.74e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—INS—type 2 diabetes mellitus	1.11e-05	6.73e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.1e-05	6.66e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	1.09e-05	6.6e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AGT—type 2 diabetes mellitus	1.07e-05	6.53e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	1.06e-05	6.44e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CALM1—type 2 diabetes mellitus	1.06e-05	6.42e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOE—type 2 diabetes mellitus	1.05e-05	6.4e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOA1—type 2 diabetes mellitus	1.04e-05	6.32e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.04e-05	6.3e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	1.02e-05	6.19e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALB—type 2 diabetes mellitus	1.02e-05	6.17e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—INS—type 2 diabetes mellitus	9.93e-06	6.03e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	9.89e-06	6.01e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKT1—type 2 diabetes mellitus	9.8e-06	5.95e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.77e-06	5.93e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3R1—type 2 diabetes mellitus	9.71e-06	5.9e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NOS3—type 2 diabetes mellitus	9.71e-06	5.9e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	9.69e-06	5.89e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	9.69e-06	5.89e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.6e-06	5.83e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.59e-06	5.83e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.55e-06	5.8e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	9.5e-06	5.77e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	9.45e-06	5.74e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	9.45e-06	5.74e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	9.45e-06	5.74e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	9.39e-06	5.7e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	9.22e-06	5.6e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—type 2 diabetes mellitus	9.17e-06	5.57e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.12e-06	5.54e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	9.11e-06	5.53e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—INS—type 2 diabetes mellitus	9e-06	5.46e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	8.95e-06	5.43e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—type 2 diabetes mellitus	8.88e-06	5.39e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.71e-06	5.29e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.71e-06	5.29e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	8.47e-06	5.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	8.47e-06	5.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	8.47e-06	5.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	8.32e-06	5.05e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	8.25e-06	5.01e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	8.24e-06	5.01e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RELA—type 2 diabetes mellitus	8.19e-06	4.98e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.08e-06	4.91e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	8.06e-06	4.9e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	7.89e-06	4.79e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	7.89e-06	4.79e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	7.75e-06	4.71e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	7.66e-06	4.65e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	7.66e-06	4.65e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.47e-06	4.54e-05	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.46e-06	4.53e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.39e-06	4.49e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.35e-06	4.46e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	7.35e-06	4.46e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.34e-06	4.46e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	7.22e-06	4.38e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.98e-06	4.24e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.91e-06	4.2e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.77e-06	4.11e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.44e-06	3.91e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.33e-06	3.85e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.33e-06	3.85e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.3e-06	3.83e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.27e-06	3.81e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.22e-06	3.78e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.04e-06	3.67e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.87e-06	3.57e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.76e-06	3.5e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.76e-06	3.5e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.64e-06	3.43e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.64e-06	3.43e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.62e-06	3.42e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.48e-06	3.33e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.41e-06	3.28e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.19e-06	3.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.09e-06	3.09e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.93e-06	2.99e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.85e-06	2.94e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.83e-06	2.93e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.78e-06	2.9e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKT1—type 2 diabetes mellitus	4.46e-06	2.71e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.34e-06	2.63e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.21e-06	2.56e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.13e-06	2.51e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT1—type 2 diabetes mellitus	4e-06	2.43e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.78e-06	2.3e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	3.63e-06	2.2e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.62e-06	2.2e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.62e-06	2.2e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.31e-06	2.01e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.66e-06	1.01e-05	CbGpPWpGaD
